NCT07171515Enrolling by invitation
Development & Clinical Application of K-PaC Registry Version 2.0
Source: ClinicalTrials.gov · Last updated 12 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Development and clinical use of pancreatic cancer registry * Development of K-PaC Registry v.2.0: Retrospective data integration from 2010 to 2022 and prospective data collection from more than 811 enrolled patients from 2023 to 2029 * Creation of clinical evidence (RWE) based on pancreatic cancer real-world data (RWD): 3 or more
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 6923 (estimated)
- First submitted
- 15 Jun 2025
- Start date
- 2 Jan 2023
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- National Cancer Center, Korea
- Diseases
- Pancreatic cancer
- NCT number
- NCT07171515
What you commit to
- Study type: Observational
- Planned participants: 6923
- From 2 Jan 2023 to the primary completion date, 31 Dec 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- In cases where medical record review is not feasible
Who the study is looking for
- Clinical diagnosis of pancreatic cancer
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Cancer Center Coordinator of this site? Confirm its status | Goyang | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.